Impact of TNF inhibitor therapy on joint replacement rates in rheumatoid arthritis: a matched cohort analysis of BSRBR-RA UK registry data
Samuel Hawley(University of Bristol), Daniel Prieto‐Alhambra(Nuffield Orthopaedic Centre), Kimme L Hyrich(Manchester Royal Infirmary), Nigel Arden(Nuffield Orthopaedic Centre), Andrew Judge(Royal College of Obstetricians and Gynaecologists), Christopher J Edwards(University Hospital Southampton NHS Foundation Trust), Lene Dreyer(Institute for Rheumatic Diseases (Japan)), René Cordtz(Gentofte Hospital), Cyrus Cooper(University Hospital Southampton NHS Foundation Trust), M. Sanni Ali(University of Oxford)
Cited by 18
Related Papers
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update
|Annals of the Rheumatic Diseases|2020|2.8k
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update
|Annals of the Rheumatic Diseases|2022|1.9k
SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe
|European Heart Journal|2021|1.7k
2022 update
|Radboud Repository (Radboud University)|2010|1.6k